- Our Story
- Our Products
- Our Science
- Our People & Citizenship
-
Investors
- Reports and Filings
- Presentations & Earnings Calls
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Details of Shares for transfer to IEPF May 2021
- Notice pursuant to IEPF Rules, May 2021
- Governance
- Investor Services
-
ESG profile
- Media
- Partners
- Contact Us
2-DG
Antiviral and anti-inflammatory drug
Discovered by the Institute of Nuclear Medicine & Allied Sciences of India’s Defence Research and Development Organisation (DRDO), 2-DG has been codeveloped by Dr. Reddy’s Laboratories as an adjunct therapy for Covid-19.
Where can you find 2-DG?
We are committed to making 2-DG available to the maximum number of people in our fight against COVID-19. If you are trying to source 2-DG, please search below. If unable to find a convenient location,
please write to us at 2DG@drreddys.com or call us on 18004250014 (Timing: 8 AM to 6 PM - Monday to Friday)